Viewing Study NCT00963820


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2025-12-26 @ 3:28 AM
Study NCT ID: NCT00963820
Status: COMPLETED
Last Update Posted: 2018-01-10
First Post: 2009-08-20
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma
Sponsor: Millennium Pharmaceuticals, Inc.
Organization: